Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Aghajanian

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Lymphology|July 18, 2000
Prostaglandin synthesis in human lymphatics from precursor fatty acidsA Oguogho, A A Aghajanian, H Sinzinger
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
[Isoprostanes, a new substance group in angiology--of future significance?]A A Aghajanian, A Oguogho, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 3, 1999
Semotiadil, a new calcium antagonist, is a very potent inhibitor of LDL-oxidationH Kritz, A Oguogho, A A Aghajanian, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Lymphology|July 18, 2000
Prostaglandin synthesis in human lymphatics from precursor fatty acidsA Oguogho, A A Aghajanian, H Sinzinger
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
[Isoprostanes, a new substance group in angiology--of future significance?]A A Aghajanian, A Oguogho, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 3, 1999
Semotiadil, a new calcium antagonist, is a very potent inhibitor of LDL-oxidationH Kritz, A Oguogho, A A Aghajanian, et al.
Pageof 1